Psychiatry and Neurology, Neurology · Seattle, WA
NPI
1942385745
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
University of Washington Medical Ctr, 1959 NE Pacific St
Seattle, WA, 98195
Phone (206) 598-5068
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
510 services
Medicare patients, 2024
176
Average age 72
Drug cost, 2024
$3.6M
800 prescriptions
Company payments, 2025
$2,300
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Barbara J Distad was code 99215 (office e&m - established), 105 times for 69 patients. In total Barbara J Distad billed 510 services in 36 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-09-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 105 | 69 | $111.42 | $12K |
| 95885 Electrical Nerve Conductivity | Facility | 78 | 52 | $15.17 | $1,183 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 78 | 29 | $26.28 | $2,050 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 39 | 31 | $13.63 | $531 |
| 99214 Office E&M - Established | Facility | 31 | 26 | $77.84 | $2,413 |
| 95910 Electrical Nerve Conductivity | Facility | 24 | 24 | $86.45 | $2,075 |
| 99205 Office E&M - New | Facility | 22 | 22 | $138.81 | $3,054 |
| 99223 Hospital E&M - Initial | Facility | 18 | 18 | $152.57 | $2,746 |
| 95909 Electrical Nerve Conductivity | Facility | 16 | 16 | $58.55 | $937 |
| 99204 Office E&M - New | Facility | 12 | 12 | $109.51 | $1,314 |
By year: 2022 $34K for 445 services; 2023 $45K for 616 services; 2024 $34K for 510 services.
Medicare prescription drug claims, 2024
In 2024, the drug Barbara J Distad prescribed most often to Medicare patients was Radicava Ors (Edaravone), with 81 prescriptions and refills. In total Barbara J Distad wrote 800 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Radicava Ors Edaravone | 81 | 81 | 12 | $1.1M |
| Gabapentin Generic | 66 | 143 | 17 | $1,058 |
| Pyridostigmine Bromide Generic | 56 | 80 | 15 | $4,044 |
| Riluzole Generic | 53 | 104 | 15 | $29K |
| Mycophenolate Mofetil Generic | 40 | 72 | Under 11 | $4,673 |
| Potassium Chloride Generic | 36 | 62 | Under 11 | $318 |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 35 | 35 | Under 11 | $333K |
| Gammaplex Immun Glob G(Igg)/Gly/Iga 0-50 | 34 | 36 | Under 11 | $431K |
| Nuedexta Dextromethorphan Hbr/Quinidine | 33 | 41 | Under 11 | $65K |
| Prednisone Generic | 27 | 38 | Under 11 | $119 |
| Azathioprine Generic | 25 | 76 | Under 11 | $3,488 |
| Baclofen Generic | 22 | 47 | Under 11 | $268 |
| Glycopyrrolate Generic | 19 | 25 | Under 11 | $1,529 |
| Zilbrysq Zilucoplan Sodium | 15 | 15 | Under 11 | $588K |
| Hizentra Immun Glob G(Igg)/Pro/Iga 0-50 | 14 | 14 | Under 11 | $147K |
Brand drugs: 314 claims; generic drugs: 486 claims; opioid claims: 13.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Barbara J Distad $2,300 ($2,300 in general payments such as food, travel and fees) from 4 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,879.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.